Purpose of the development: For treatment of animals against anthrax.

Recommended application field: Veterinary science.

Technical characteristic: The vaccine is produced in vials at 10.20 cm. cube or 25 and 50 cm cube.Preserved at 2-8 C, the working life - 24 months.

The development stage readiness: Introduced in production

Description of the development:
()
Developed a highly efficient, which has no analogues in the world vaccine "Antrokol" for the treatment of animals against anthrax. The vaccine is made from extracelular products (metabolites) of the vaccinal strain Bac.Anthrocis K-79Z. Suitable for all types of animals for prophylactic and therapeutic purposes directly in outbreaks of disease and in the zone of possible outbreaks for rapid creation of immunity to the disease. Vaccine "Antrokol" is promising to vaccination, even of such animals, which are prohibited to immunize with a live spore vaccine (young age of three months, sport animals, etc). Contraindications are not established.The vaccine should be put subcutaneously or internally according to the rules of antisepsis. The vaccine is tested on the territory of Ukraine in outbreaks of anthrax on sheep, fur animals and cattle.The total number of livestock was over 10,000. All the sick animals got over, among vaccinated there are no reported outbreaks of the disease. Production and quality control of vaccines "Antrokol" is approved by regulatory documents. There is industrial production of the medicine. Cooperation proposals:- end product delivery;- joint production.

corresponds technical description
Conforms to technical characteristic

Possibility of transfer abroad:
Licence's sale
Realization of finished commodity
Joint production, sale, exploitation

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua